Filing Details
- Accession Number:
- 0001181431-13-039975
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-15 16:48:26
- Reporting Period:
- 2013-07-11
- Filing Date:
- 2013-07-15
- Accepted Time:
- 2013-07-15 16:48:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1290166 | Qvt Associates Gp Llc | 1177 Avenue Of The Americas 9Th Floor New York NY 10036 | No | No | Yes | No | |
1543904 | Qvt Fund V Lp | 1177 Avenue Of The Americas 9Th Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2013-07-11 | 341,355 | $6.46 | 14,305,909 | No | 4 | P | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
Common Stock, $0.001 Par Value | Acquisiton | 2013-07-11 | 59,662 | $6.47 | 14,365,571 | No | 4 | P | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |
No | 4 | P | Indirect | Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. |